ES2945983T3 - Glucocorticoides muy potentes - Google Patents

Glucocorticoides muy potentes Download PDF

Info

Publication number
ES2945983T3
ES2945983T3 ES17860202T ES17860202T ES2945983T3 ES 2945983 T3 ES2945983 T3 ES 2945983T3 ES 17860202 T ES17860202 T ES 17860202T ES 17860202 T ES17860202 T ES 17860202T ES 2945983 T3 ES2945983 T3 ES 2945983T3
Authority
ES
Spain
Prior art keywords
alkyl
group
compound
dex
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17860202T
Other languages
English (en)
Spanish (es)
Inventor
Huaqiang Xu
Yuanzheng He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Andel Research Institute
Original Assignee
Van Andel Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Research Institute filed Critical Van Andel Research Institute
Application granted granted Critical
Publication of ES2945983T3 publication Critical patent/ES2945983T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES17860202T 2016-10-14 2017-10-13 Glucocorticoides muy potentes Active ES2945983T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662408314P 2016-10-14 2016-10-14
PCT/US2017/056447 WO2018071736A1 (en) 2016-10-14 2017-10-13 Structures and mechanism for the design of highly potent glucocorticoids

Publications (1)

Publication Number Publication Date
ES2945983T3 true ES2945983T3 (es) 2023-07-11

Family

ID=61906432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17860202T Active ES2945983T3 (es) 2016-10-14 2017-10-13 Glucocorticoides muy potentes

Country Status (12)

Country Link
US (1) US10954265B2 (cg-RX-API-DMAC7.html)
EP (1) EP3525870B1 (cg-RX-API-DMAC7.html)
JP (2) JP7146750B2 (cg-RX-API-DMAC7.html)
KR (1) KR102497070B1 (cg-RX-API-DMAC7.html)
CN (1) CN110382033B (cg-RX-API-DMAC7.html)
ES (1) ES2945983T3 (cg-RX-API-DMAC7.html)
MA (1) MA46539A (cg-RX-API-DMAC7.html)
PH (1) PH12019500801A1 (cg-RX-API-DMAC7.html)
RU (1) RU2019111101A (cg-RX-API-DMAC7.html)
SG (1) SG11201903209TA (cg-RX-API-DMAC7.html)
WO (1) WO2018071736A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201902595B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025119398A1 (zh) * 2023-12-08 2025-06-12 浙江柏拉阿图医药科技有限公司 高效力糖皮质激素多晶型及其制备方法和用途
CN120365344A (zh) * 2024-01-24 2025-07-25 浙江柏拉阿图医药科技有限公司 一种高效力糖皮质激素化合物及其制备和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK66202C (da) 1945-03-03 1948-01-12 Danske Securitas As Kodekontakt til elektriske Alarmanlæg.
DK71662C (da) 1946-09-05 1950-11-06 Ingenioer Frank Broadbent Tørrecentrifuge.
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
CA2451057A1 (en) 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
JP2007511521A (ja) * 2003-11-13 2007-05-10 コンビナトアールエックス インコーポレーティッド 炎症性障害を治療する方法および試薬
JP5216589B2 (ja) * 2005-09-02 2013-06-19 ニコックス エス エイ ステロイドのニトロオキシ誘導体
CN1813768A (zh) * 2005-11-18 2006-08-09 成都力思特制药股份有限公司 治疗呼吸系统疾病的药用组合物及其在制药中的应用
NZ584160A (en) * 2007-10-04 2011-05-27 Astrazeneca Ab Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
CA2707618A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Steroid derivatives acting as glucocorticosteroid receptor agonists
CA2749585A1 (en) 2009-01-13 2010-07-22 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
UY32525A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
WO2010147947A2 (en) 2009-06-16 2010-12-23 Schering Corporation NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
WO2015048316A1 (en) * 2013-09-25 2015-04-02 Van Andel Research Institute Highly potent glucocorticoids
TWI695831B (zh) * 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Crth2拮抗劑化合物及其用途

Also Published As

Publication number Publication date
EP3525870A1 (en) 2019-08-21
KR102497070B1 (ko) 2023-02-06
SG11201903209TA (en) 2019-05-30
US10954265B2 (en) 2021-03-23
EP3525870A4 (en) 2020-04-29
US20190263853A1 (en) 2019-08-29
JP2022132464A (ja) 2022-09-08
JP2019532071A (ja) 2019-11-07
MA46539A (fr) 2019-08-21
CN110382033A (zh) 2019-10-25
WO2018071736A1 (en) 2018-04-19
WO2018071736A9 (en) 2019-05-23
RU2019111101A3 (cg-RX-API-DMAC7.html) 2020-11-27
PH12019500801A1 (en) 2019-11-11
CN110382033B (zh) 2022-04-15
EP3525870B1 (en) 2023-05-10
KR20190068577A (ko) 2019-06-18
ZA201902595B (en) 2021-04-28
JP7146750B2 (ja) 2022-10-04
RU2019111101A (ru) 2020-11-16

Similar Documents

Publication Publication Date Title
ES2751457T3 (es) Glucocorticoides altamente potentes
KR102483876B1 (ko) 아미노 피리미딘 ssao 억제제
UA128369C2 (uk) Сполуки, що інгібують rip1, а також способи їх одержання та застосування
ES2658168T3 (es) Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas
JP6842474B2 (ja) ステロイド系化合物、当該化合物を含む組成物及びその使用
EP3152209B1 (en) Naphthyridinedione derivatives as suppressors of non-sense mutations
EP3148970B1 (en) Androgen receptor modulators and methods for their use
TW202327620A (zh) 一種抗炎症的化合物及其用途
ES2945983T3 (es) Glucocorticoides muy potentes
ES2866698T3 (es) Derivados de Aureobasidina y métodos de síntesis
JP2022523668A (ja) Magl阻害剤による疾病の治療方法
Zhang et al. Design, synthesis, and bioevaluation of novel NLRP3 inhibitor with IBD immunotherapy from the virtual screen
JP2014515741A5 (cg-RX-API-DMAC7.html)
TWI746660B (zh) 尿素衍生物及其用途
HK40017057B (zh) 用於设计高效力糖皮质激素的结构与机制
HK40017057A (en) Structures and mechanism for the design of highly potent glucocorticoids
HK40070300A (en) Highly potent glucocorticoids
WO2025157225A1 (zh) 一种高效力糖皮质激素化合物及其制备和用途
TWI776810B (zh) 新穎二胺基吡啶衍生物
JP2009517424A (ja) スルファモイルスルホネートプロドラッグ
HK1230182B (en) Naphthyridinedione derivatives as suppressors of non-sense mutations
HK1230182A1 (en) Naphthyridinedione derivatives as suppressors of non-sense mutations